Inactief instrument

Andere talen PsyBio Therapeutics Corp. Toronto S.E.

Aandelen

PSYB

CA5263612098

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

PsyBio Therapeutics : Reports Second Quarter 2021 Financial Results and Provides Corporate Update on Intellectual Property and Clinical Development Milestones	30-08-21
PsyBio Therapeutics : Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs	16-08-21
PsyBio Therapeutics Files Patent Application with USPTO for Production Methods of Methylated Trypatamines and Associated Analogs	16-08-21
PsyBio Therapeutics : Adds NMDA Receptor Antagonists and Associated Analogues into its Intellectual Property Portfolio	04-08-21
PsyBio Therapeutics : CEO and CMO to Participate in Fireside Chat at LifeSci Partners Summer Symposium	20-07-21
PsyBio Therapeutics : Announces Uplisting to OTCQB Venture Market	14-07-21
PsyBio Therapeutics : Files Novel Psychedelic Compositions and Methods of Treatment Patent With USPTO	13-07-21
PsyBio Therapeutics : Augments Intellectual Property Portfolio with Filing of Next Novel Psychedelic Compositions and Methods of Treatment Patent	13-07-21
PsyBio Therapeutics : Announces TSXV Approval of Share Buyback Program	28-06-21
Psybio Therapeutics Corp. Initiates European Manufacturing of Proprietary Biosynthetic Psychedelic Compounds	22-06-21
PsyBio Therapeutics : Initiates European Manufacturing of Proprietary Biosynthetic Psychedelic Compounds including Psilocybin with France-based Biose Industrie	22-06-21
PsyBio Therapeutics Corp. Announces Executive Changes	01-06-21
PsyBio Therapeutics Corp.'s Board intends to launch an Equity Buyback.	01-06-21
IRW-News: PsyBio Therapeutics Corp.: PsyBio Therapeutics beruft erfahrene pharmazeutische Führungskraft Bob Oliver in sein Board of Directors	21-04-21
PsyBio Therapeutics : Appoints Pharmaceutical Veteran Bob Oliver to its Board of Directors	21-04-21
PsyBio Therapeutics : Retains KCSA Strategic Communications for Investor Relations Services	09-04-21
PsyBio Therapeutics : Strengthens Leadership Team with Appointment of Dr. Michael Spigarelli as Chief Medical Officer	05-04-21
PsyBio Therapeutics : Strengthens its Leadership Team with Appointment of Dr. Michael Spigarelli as Chief Medical Officer	05-04-21
IRW-News: PsyBio Therapeutics Corp.: PsyBio Therapeutics beginnt mit Prozessentwicklung von eigenem biosynthetischem Norbaeocystin	23-03-21
PsyBio Therapeutics Announces Retention of Market Maker	04-03-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen PsyBio Therapeutics Corp. Toronto S.E.

Aandelen

PSYB

CA5263612098

Andere talen

Filters